By I. Edwards HealthDay ReporterWEDNESDAY, June 18, 2025 (HealthDay News) — Drugmaker Eli Lilly plans to buy Verve Therapeutics, a gene-editing startup, for about $1 billion upfront.The deal gives Lilly …
Researchers Quantify Magnitude of Cardiovascular Risk Associated With Cannabis
Increased estimated risk ratios seen for nonfatal acute coronary syndrome, stroke, cardiovascular death
FDA Offers Speedier Approvals to Drug Companies Aligning With ‘National Priorities’
Agency is offering vouchers to some drug manufacturers to shorten review time for final drug applications
‘Gas Station Heroin’ Spurs Spike in Poison Control Calls, FDA Warns
By Carole Tanzer Miller HealthDay ReporterTUESDAY, June 17, 2025 (HealthDay News) — The small, colorful bottles hawked at convenience stores, smoke shops and filling stations as cognitive supplements or energy …
Virtual Reality Training Module May Aid Infection Control Efforts
Users report an overall positive experience for module covering cleaning and disinfecting portable medical equipment
Prenatal PFAS Exposure Linked to Elevated BP Through Adolescence
Each doubling of perfluoroheptanesulfonic acid linked to 9 and 17 percent higher risk for elevated BP at ages 6 to 12, 13 to 18 years, respectively, in male children
Survival Up for CABG With Surgical Ablation in Atrial Fibrillation
Medicare beneficiaries undergoing concomitant surgical ablation have risk-adjusted median survival advantage
Real-World Weight Loss With Semaglutide, Tirzepatide Less Than That Seen in Clinical Trials
In real-world cohort, percentage weight reduction at one year was 3.6, 6.8, and 11.9 percent with early and late discontinuation and nondiscontinuation, respectively
Adherence to Healthy Diet Improves Cardiometabolic Risk, Even Without Weight Loss
Authors say findings reframe clinical success of lifestyle interventions
FDA Approves Polypill Widaplik for Hypertension
Approval marks first triple-combination pill of telmisartan, amlodipine, and indapamide